Company Cotinga Pharmaceuticals Inc. Toronto S.E.
Equities
COT.H
CA22164W1059
Biotechnology & Medical Research
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
David Sanderson
BRD | Director/Board Member | - | 13-12-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,986,415 | 15,211,245 ( 69.18 %) | 0 | 69.18 % |
Company contact information
Cotinga Pharmaceuticals, Inc.
127 Main Street
02129, Boston
+
Sector
1st Jan change | Capi. | |
---|---|---|
+8.32% | 115B | |
+12.82% | 107B | |
-13.67% | 22.31B | |
-3.96% | 21.6B | |
-6.00% | 18.23B | |
-39.93% | 17.62B | |
+7.35% | 14.26B | |
+33.53% | 12.37B | |
-27.17% | 8.28B |